This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the full ASCO 2019 update for AMG 510 after Amgen's Analyst call on Monday

Ticker(s): AMGN

Who's the expert?

A medical oncologist who has attended and is very familiar with the KRAS data.

Interview Goal
This conversation will take a look at the full update on AMG 510 after ASCO 2019. We'll get an expert's opinion on the specific data as well as applicability to oncology broadly.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.


*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.